CLGN

Collplant Biotechnologies Ltd (CLGN) | Rumor.io

Collplant Biotechnologies

CLGN

Attention (50-day avg)0%

Attention rank (50-day avg)#1,418

Bullish sentiment (50-day avg)75%

Price to earnings ratio-4.06

Market capitalization7.3M

Earnings per share-10.4

Dividend yield (TTM)—

Revenue (annual)2.4M

Net income (annual)-11.5M

Social

What share of all stock conversation is about CLGN?

	1 Day1D	1 Week1W	1 Month1M	1 Year1Y	50-Day MAclick to plot	200-Day MAclick to plot
Attention	0% 0	0% 0	0% +0	0% 0

Sep 18

CLGN has jumped due to increased exposure and understanding of its story, and some investors are buying more shares.
The acquisition structure of CLGN's purchase of LightSolver is complicated, involving substantial share issuance, pre-funded warrants, and potential milestone-warrant shares, leading to dilution concerns.
CLGN's stock price is showing potential, with some analysts expecting it to retest $9, and the company's recent acquisition and funding are seen as positive developments.

Generated by AI

Sentiment

Of the messages about CLGN that take a side, what share is each?

	1 Day1D	1 Week1W	1 Month1M	1 Year1Y	50-Day MAclick to plot	200-Day MAclick to plot
Bullish	—	—	75.7% +25.7	76.1% -18.34
Bearish	—	—	24.3% -25.7	23.9% +18.34

Bullish· Sep 1

The company's recent acquisition of LightSolver is expected to enter the supercomputing and photonics computing markets, potentially leading to significant growth.
The company's partnership with Boeing and other tech companies is expected to bring in $84M in revenues, providing a strong foundation for future growth.
The company's price has been subject to pump and dump schemes, but the author believes the recent dip is a buying opportunity, and the company's fundamentals are strong enough to overcome the short-term market volatility.

Bearish· Aug 31

$CLGN has been experiencing a significant gap, with a big drop from $1.10.
The company's recent earnings announcement is expected to be negative, with some users predicting a loss.
CollPlant Biotechnologies Ltd. is facing a massive distribution, with some users calling it a "shit" stock.

Generated by AI

Topics

Of the messages about CLGN that carry a topic, what share is each?

	1 Day1D	1 Week1W	1 Month1M	1 Year1Y
Announcements	—	100%	56.49%	67.65%
Earnings	—	0%	1.3%	1.68%
Technical Analysis	—	0%	42.21%	28.57%
Analysts	—	0%	0%	0.42%
Controversies	—	0%	0%	1.68%
Macro	—	0%	0%	0%

Aug 31

CollPlant Biotechnologies (CLGN) has acquired LightSolver, a deep-tech company, in a deal that includes 3.73M shares and milestone warrants for 224.08M shares.
The acquisition will allow CLGN to enter the supercomputing and photonic computing markets, with LightSolver's Laser Processing Unit (LPU) technology as the centerpiece.
CLGN's stock price has surged 174% following the announcement, with the company's market capitalization increasing to $6M and its enterprise value rising to $4M.

Generated by AI

Community

Of the messages about CLGN, what share comes from each group?

	1 Day1D	1 Week1W	1 Month1M	1 Year1Y	50-Day MAclick to plot	200-Day MAclick to plot
Regulars	100%	37.5%	7.08%	14.39%
Newcomers	0%	62.5%	92.92%	85.61%

Regulars· Aug 31

The acquisition of LightSolver by CollPlant Biotechnologies is a significant move, as LightSolver is developing a pure photonic computing architecture that could revolutionize the computing industry.
The LightSolver Laser Processing Unit (LPU) is designed to be an all-optical computing layer, targeting the supercomputing and photonic computing markets, and the deal's terms and implications are being closely watched by regulars.
CollPlant Biotechnologies' stock is surging after the acquisition announcement, but some regulars are cautious about the stock's volatility and uncertainty about the company's future prospects.

Newcomers· Sep 18

The newcomer is focusing on the potential of CollPlant Biotechnologies Ltd. (CLGN) as a result of its acquisition of LightSolver, seeing it as a way to gain exposure to the light-computing market without the risks associated with investing in LightSolver directly.
The dilution of shares resulting from the acquisition is a key concern, with the SEC filing showing substantial share issuance, pre-funded warrants, and potential milestone-warrant shares that could impact the company's value.
The newcomer is optimistic about the future of CLGN, seeing it as a way to invest in the emerging light-computing market, with the company potentially retesting its previous price of $9.

Generated by AI

News

CollPlant regains Nasdaq compliance on minimum bid price

7d agoInvesting.com

CollPlant Highlights LightSolver Optical Computing Strategy in Updated September 2026 Presentation

Detailed price information for Collplant Biotechnologies Ltd ADR (CLGN-Q) from The Globe and Mail including charting and trades.

10d agoThe Globe and Mail

CollPlant Biotechnologies Ltd. (CLGN) Discusses Acquisition of Lightsolver and Strategic Entry Into High-Performance Photonic Computing - Slideshow (NASDAQ:CLGN) 2026-09-18

11d agoSeeking Alpha

CollPlant to Host LightSolver Investor Webinar on September 17, 2026

20d agobarchart.com

CollPlant Adds LightSolver Founder to Board After Closing Photonic Computing Acquisition

Detailed price information for Collplant Biotechnologies Ltd ADR (CLGN-Q) from The Globe and Mail including charting and trades.

25d agoThe Globe and Mail

CollPlant Closes LightSolver Acquisition, Expands Into Photonic Computing

Detailed price information for Collplant Biotechnologies Ltd ADR (CLGN-Q) from The Globe and Mail including charting and trades.

25d agoThe Globe and Mail

Also Discussed

Investors talking about CLGN also mention

#	Name	Attention
1	Golden Sun Technology Group LimitedGSUN	0%new
2	Zhongchao Inc. Class A Ordinary SharesZCMD	0%new
3	The First Bancorp, Inc.FNLC	0%0
4	Decent Holding Inc. Class A Ordinary SharesDXST	0.02%new
5	TNL Mediagene Ordinary SharesTNMG	0%new
6	DALN - DallasNews Corporation	——
7	Baird Medical Investment Holdings Ltd.BDMD	0%new
8	LifeVantage CorporationLFVN	0%new
9	Lake Shore Bancorp, Inc.LSBK	0%0
10	Westwood Holdings Group Inc.WHG	0%0

Collplant Biotechnologies Ltd

Healthcare
Biotechnology

CollPlant Biotechnologies Ltd. is a regenerative and aesthetic medicine company focused on developing medical products based on its recombinant human collagen technology. The company’s current portfolio centers on 3D bioprinting for tissues and organs, tissue repair, advanced wound care, and medical aesthetics. Its offerings include bioinks and collagen-based materials designed for regenerative applications, along with products used in soft tissue repair and wound management. CollPlant Biotechnologies also works with partners and collaborators in the broader medical device and biotech ecosystem, supporting applications in orthobiologics, surgical repair, and aesthetic medicine. Headquartered in Rehovot, Israel, CollPlant Biotechnologies Ltd. plays a niche role in the market by combining plant-based biotechnology with collagen innovation for healthcare uses.

Website

Location

Weizmann Science Park

Rehovot, 7670104

Israel

Social

What share of all stock conversation is about CLGN?

	1 Day1D	1 Week1W	1 Month1M	1 Year1Y	50-Day MAclick to plot	200-Day MAclick to plot
Attention	0% 0	0% 0	0% +0	0% 0

Sep 18

CLGN has jumped due to increased exposure and understanding of its story, and some investors are buying more shares.
The acquisition structure of CLGN's purchase of LightSolver is complicated, involving substantial share issuance, pre-funded warrants, and potential milestone-warrant shares, leading to dilution concerns.
CLGN's stock price is showing potential, with some analysts expecting it to retest $9, and the company's recent acquisition and funding are seen as positive developments.

Generated by AI

Sentiment

Of the messages about CLGN that take a side, what share is each?

	1 Day1D	1 Week1W	1 Month1M	1 Year1Y	50-Day MAclick to plot	200-Day MAclick to plot
Bullish	—	—	75.7% +25.7	76.1% -18.34
Bearish	—	—	24.3% -25.7	23.9% +18.34

Bullish· Sep 1

The company's recent acquisition of LightSolver is expected to enter the supercomputing and photonics computing markets, potentially leading to significant growth.
The company's partnership with Boeing and other tech companies is expected to bring in $84M in revenues, providing a strong foundation for future growth.
The company's price has been subject to pump and dump schemes, but the author believes the recent dip is a buying opportunity, and the company's fundamentals are strong enough to overcome the short-term market volatility.

Bearish· Aug 31

$CLGN has been experiencing a significant gap, with a big drop from $1.10.
The company's recent earnings announcement is expected to be negative, with some users predicting a loss.
CollPlant Biotechnologies Ltd. is facing a massive distribution, with some users calling it a "shit" stock.

Generated by AI

Topics

Of the messages about CLGN that carry a topic, what share is each?

	1 Day1D	1 Week1W	1 Month1M	1 Year1Y
Announcements	—	100%	56.49%	67.65%
Earnings	—	0%	1.3%	1.68%
Technical Analysis	—	0%	42.21%	28.57%
Analysts	—	0%	0%	0.42%
Controversies	—	0%	0%	1.68%
Macro	—	0%	0%	0%

Aug 31

CollPlant Biotechnologies (CLGN) has acquired LightSolver, a deep-tech company, in a deal that includes 3.73M shares and milestone warrants for 224.08M shares.
The acquisition will allow CLGN to enter the supercomputing and photonic computing markets, with LightSolver's Laser Processing Unit (LPU) technology as the centerpiece.
CLGN's stock price has surged 174% following the announcement, with the company's market capitalization increasing to $6M and its enterprise value rising to $4M.

Generated by AI

Community

Of the messages about CLGN, what share comes from each group?

	1 Day1D	1 Week1W	1 Month1M	1 Year1Y	50-Day MAclick to plot	200-Day MAclick to plot
Regulars	100%	37.5%	7.08%	14.39%
Newcomers	0%	62.5%	92.92%	85.61%

Regulars· Aug 31

The acquisition of LightSolver by CollPlant Biotechnologies is a significant move, as LightSolver is developing a pure photonic computing architecture that could revolutionize the computing industry.
The LightSolver Laser Processing Unit (LPU) is designed to be an all-optical computing layer, targeting the supercomputing and photonic computing markets, and the deal's terms and implications are being closely watched by regulars.
CollPlant Biotechnologies' stock is surging after the acquisition announcement, but some regulars are cautious about the stock's volatility and uncertainty about the company's future prospects.

Newcomers· Sep 18

The newcomer is focusing on the potential of CollPlant Biotechnologies Ltd. (CLGN) as a result of its acquisition of LightSolver, seeing it as a way to gain exposure to the light-computing market without the risks associated with investing in LightSolver directly.
The dilution of shares resulting from the acquisition is a key concern, with the SEC filing showing substantial share issuance, pre-funded warrants, and potential milestone-warrant shares that could impact the company's value.
The newcomer is optimistic about the future of CLGN, seeing it as a way to invest in the emerging light-computing market, with the company potentially retesting its previous price of $9.

Generated by AI

Collplant Biotechnologies

Social

Sep 18

Bullish· Sep 1

Bearish· Aug 31

Aug 31

Regulars· Aug 31

Newcomers· Sep 18

CollPlant regains Nasdaq compliance on minimum bid price

CollPlant Highlights LightSolver Optical Computing Strategy in Updated September 2026 Presentation

CollPlant Biotechnologies Ltd. (CLGN) Discusses Acquisition of Lightsolver and Strategic Entry Into High-Performance Photonic Computing - Slideshow (NASDAQ:CLGN) 2026-09-18

CollPlant to Host LightSolver Investor Webinar on September 17, 2026

CollPlant Adds LightSolver Founder to Board After Closing Photonic Computing Acquisition

CollPlant Closes LightSolver Acquisition, Expands Into Photonic Computing

Also Discussed

Collplant Biotechnologies Ltd

Company Information

Location

CollPlant regains Nasdaq compliance on minimum bid price

CollPlant Highlights LightSolver Optical Computing Strategy in Updated September 2026 Presentation

CollPlant Biotechnologies Ltd. (CLGN) Discusses Acquisition of Lightsolver and Strategic Entry Into High-Performance Photonic Computing - Slideshow (NASDAQ:CLGN) 2026-09-18

CollPlant to Host LightSolver Investor Webinar on September 17, 2026

CollPlant Adds LightSolver Founder to Board After Closing Photonic Computing Acquisition

CollPlant Closes LightSolver Acquisition, Expands Into Photonic Computing

Also Discussed

Social

Sep 18

Bullish· Sep 1

Bearish· Aug 31

Aug 31

Regulars· Aug 31

Newcomers· Sep 18